Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Synergism Between Chemotherapy with 6-Mercaptopurine and DNA Vaccination Against Ph + Acute Lymphoblastic Leukemia In Syngeneic Mice

Yvonne Rott, Manuel Schmidt, Burghardt Wittig, Egbert Herting, Joachim Köchling

Blood (2010) 116 (21): 3265.

https://doi.org/10.1182/blood.V116.21.3265.3265

Published: 2010

Journal Articles

Antileukemic Efficacy of Anthocyanins In-Vitro and In-Vivo and In Combination with a DNA Vaccine Against Ph + Acute Lymphoblastic Leukemia

Yvonne Rott, Michael Sagner, Hendrik Ungefroren, Manuel Schmidt, Burghardt Wittig, Egbert Herting, Joachim Köchling

Blood (2010) 116 (21): 3267.

https://doi.org/10.1182/blood.V116.21.3267.3267

Published: 2010

Journal Articles

MGN1703, a Novel TLR9-Agonist - Results of a Phase 1 Clinical Trial in Patients with Metastatic Malignancies.

Martin R Weihrauch, Manuel Schmidt, Marina Tschaika, Heike Richly, Michael S von Bergwelt-Baildon, Ulrich Hacker, Alexander Shimabokuro-Vornhagen, Burghardt Wittig, Max E Scheulen

Blood (2009) 114 (22): 4730.

https://doi.org/10.1182/blood.V114.22.4730.4730

Published: 2009

Journal Articles

Synergism Between Imatinib Mesylate and a BCR-ABL-Specific DNA Vaccine against Pre-Established Ph + Acute Lymphoblastic Leukemia in Syngeneic Mice.

Yvonne Rott, Stefanie Arndt, Christine Marschke, Renata Stripecke, Burghardt Wittig, Manuel Schmidt, Joachim Köchling

Blood (2009) 114 (22): 3095.

https://doi.org/10.1182/blood.V114.22.3095.3095

Published: 2009

Journal Articles

Optimization of a BCR-ABL-Specific DNA Vaccine against Ph+ ALL Using a Nonviral Vector System and Nanoparticle Delivery

Yvonne Rott, Stefanie Arndt, Jordan Green, Daniel Anderson, Renata Stripecke, Burghardt Wittig, Manuel Schmidt, Joachim Köchling

Blood (2008) 112 (11): 4625.

https://doi.org/10.1182/blood.V112.11.4625.4625

Published: 2008

Journal Articles

Prevention of Ph + Acute Lymphoblastic Leukemia by Nanoparticulate Delivery of a DNA Vaccine in Syngeneic Mice.

Joachim Koechling, MD, Yvonne Rott, Stefanie Arndt, Jordan Green, Ph.D., Daniel Anderson, Ph.D., Robert Langer, Ph.D., Renata Stripecke, Ph.D., Burghardt Wittig, M.D. Ph. D, Manuel Schmidt

Blood (2007) 110 (11): 5135.

https://doi.org/10.1182/blood.V110.11.5135.5135

Published: 2007

Journal Articles

BCR-ABL Specific Sequences Are Required To Prevent Ph + Acute Lymphoblastic Leukemia in Syngeneic Mice by DNA Vaccination.

Joachim Köchling, Javier Prada, Masoud Bahrami, Sven A. König Merediz, Renata Stripecke, Karl Seeger, Günter Henze, Burghardt Wittig, Manuel Schmidt

Blood (2006) 108 (11): 3262.

https://doi.org/10.1182/blood.V108.11.3262.3262

Published: 2006

Journal Articles

dSLIM Immunomodulators Induce Anti-Tumor Responses Both In Vitro and In Vivo .

Manuel Schmidt, Javier de Cristobal, Astrid Sander, Bernadette Brzezicha, Sven A. König Merediz, Burghardt Wittig

Blood (2006) 108 (11): 1727.

https://doi.org/10.1182/blood.V108.11.1727.1727

Published: 2006

Journal Articles

Interferon Regulatory Factor 4 Is Not Required for Induction of Chronic Myeloid Leukaemia-Like Myeloproliferative Disease by Bcr/Abl in Mice.

Anna Lena Illert, MD, Cornelius Miething, MD, Rebekka Grundler, PhD, Manuel Schmidt, PhD, Andreas Burchert, MD, Andreas Neubauer, MD, Claudia Mugler, Christian Peschel, MD, Justus Duyster, MD

Blood (2005) 106 (11): 2866.

https://doi.org/10.1182/blood.V106.11.2866.2866

Published: 2005

Journal Articles

Potent Phosphorodiester-Based DNA Immunomodulators (dSLIM) Exhibit Enhanced Safety Compared to Phosphorothioate-Based Oligonucleotides.

Manuel Schmidt, Javier de Christobal, Nicole Hagner, Astrid Sander, Alberto Marco, Sven A. Koenig-Merediz, Burghardt Wittig

Blood (2005) 106 (11): 3915.

https://doi.org/10.1182/blood.V106.11.3915.3915

Published: 2005

Journal Articles

dSLIM Immunomodulators Induce Anti-Tumor Responses Both In Vitro and In Vivo .

Manuel Schmidt, Javier de Cristobal, Astrid Sander, Bernadette Brzezicha, Sven A. Koenig-Merediz, Burghardt Wittig

Blood (2005) 106 (11): 5527.

https://doi.org/10.1182/blood.V106.11.5527.5527

Published: 2005

Journal Articles

Interferon consensus sequence binding protein (ICSBP; IRF-8) antagonizes BCR/ABL and down-regulates bcl-2

Andreas Burchert, Dali Cai, Lorenz C. Hofbauer, Magnus K. R. Samuelsson, Emily P. Slater, Justus Duyster, Markus Ritter, Andreas Hochhaus, Rolf Müller, Martin Eilers, Manuel Schmidt, Andreas Neubauer

Blood (2004) 103 (9): 3480–3489.

https://doi.org/10.1182/blood-2003-08-2970

Published: 2004

Journal Articles

Interferon-α, but not the ABL-kinase inhibitor imatinib (STI571), induces expression of myeloblastin and a specific T-cell response in chronic myeloid leukemia

Andreas Burchert, Stefan Wölfl, Manuel Schmidt, Cornelia Brendel, Barbara Denecke, Dali Cai, Larissa Odyvanova, Tanja Lahaye, Martin C. Müller, Thomas Berg, Harald Gschaidmeier, Burghardt Wittig, Rüdiger Hehlmann, Andreas Hochhaus, Andreas Neubauer

Blood (2003) 101 (1): 259–264.

https://doi.org/10.1182/blood-2002-02-0659

Published: 2003

Journal Articles

Expression of nuclear transcription factor interferon consensus sequence binding protein in chronic myeloid leukemia correlates with pretreatment risk features and cytogenetic response to interferon-α

Manuel Schmidt, Andreas Hochhaus, Andreas Nitsche, Rüdiger Hehlmann, Andreas Neubauer

Blood (2001) 97 (11): 3648–3650.

https://doi.org/10.1182/blood.V97.11.3648

Published: 2001

Journal Articles

Lack of Interferon Consensus Sequence Binding Protein ( ICSBP ) Transcripts in Human Myeloid Leukemias

Manuel Schmidt, Stefan Nagel, Jutta Proba, Christian Thiede, Markus Ritter, Jeffrey F. Waring, Frank Rosenbauer, Dieter Huhn, Burghardt Wittig, Ivan Horak, Andreas Neubauer

Blood (1998) 91 (1): 22–29.

https://doi.org/10.1182/blood.V91.1.22

Published: 1998

NARROW

Synergism Between Chemotherapy with 6-Mercaptopurine and DNA Vaccination Against Ph + Acute Lymphoblastic Leukemia In Syngeneic Mice

Antileukemic Efficacy of Anthocyanins In-Vitro and In-Vivo and In Combination with a DNA Vaccine Against Ph + Acute Lymphoblastic Leukemia

MGN1703, a Novel TLR9-Agonist - Results of a Phase 1 Clinical Trial in Patients with Metastatic Malignancies.

Synergism Between Imatinib Mesylate and a BCR-ABL-Specific DNA Vaccine against Pre-Established Ph + Acute Lymphoblastic Leukemia in Syngeneic Mice.

Optimization of a BCR-ABL-Specific DNA Vaccine against Ph+ ALL Using a Nonviral Vector System and Nanoparticle Delivery

Prevention of Ph + Acute Lymphoblastic Leukemia by Nanoparticulate Delivery of a DNA Vaccine in Syngeneic Mice.

BCR-ABL Specific Sequences Are Required To Prevent Ph + Acute Lymphoblastic Leukemia in Syngeneic Mice by DNA Vaccination.

dSLIM Immunomodulators Induce Anti-Tumor Responses Both In Vitro and In Vivo .

Interferon Regulatory Factor 4 Is Not Required for Induction of Chronic Myeloid Leukaemia-Like Myeloproliferative Disease by Bcr/Abl in Mice.

Potent Phosphorodiester-Based DNA Immunomodulators (dSLIM) Exhibit Enhanced Safety Compared to Phosphorothioate-Based Oligonucleotides.

dSLIM Immunomodulators Induce Anti-Tumor Responses Both In Vitro and In Vivo .

Interferon consensus sequence binding protein (ICSBP; IRF-8) antagonizes BCR/ABL and down-regulates bcl-2

Interferon-α, but not the ABL-kinase inhibitor imatinib (STI571), induces expression of myeloblastin and a specific T-cell response in chronic myeloid leukemia

Expression of nuclear transcription factor interferon consensus sequence binding protein in chronic myeloid leukemia correlates with pretreatment risk features and cytogenetic response to interferon-α

Lack of Interferon Consensus Sequence Binding Protein ( ICSBP ) Transcripts in Human Myeloid Leukemias

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only